Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_assertion type Assertion NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_head.
- NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_assertion description "[Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_provenance.
- NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_assertion evidence source_evidence_literature NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_provenance.
- NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_assertion SIO_000772 21098700 NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_provenance.
- NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_assertion wasDerivedFrom befree-2016 NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_provenance.
- NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_assertion wasGeneratedBy ECO_0000203 NP853952.RAvpPKqO30yulQmqzFbwMMpQ1nc1_c72VcSdYJVo9QbVw130_provenance.